FMCSA · 49 CFR Part 40 · Kansas City
DOT 5 Panel Drug Testing Kansas City
The federally mandated 5-panel drug test required for all DOT-regulated safety-sensitive employees. Screens 5 drug categories covering 14 individual substances, including expanded opioids since January 2018. Collected under strict 49 CFR Part 40 chain-of-custody procedures.
- 14 substances
- SAMHSA-certified lab
- MRO reviewed
- Part 40 chain of custody
Quick facts
- Federally mandated for all DOT safety-sensitive employees
- 5 panels: 14 individual substances screened
- Urine specimen collection: Part 40 compliant
- SAMHSA-certified lab analysis plus MRO review
- Negative results typically within 24–48 hours
- Cost: $60–$99 based on services needed
About this test
What is the DOT 5 panel drug test?
The federally mandated drug testing standard for safety-sensitive employees under Department of Transportation regulations.
Conducted at HHS-certified (SAMHSA-certified) laboratories, it screens urine specimens for five categories of controlled substances. Collected under the strict chain-of-custody procedures required by 49 CFR Part 40, every specimen is analysed, reviewed by a Medical Review Officer and reported under proper regulatory protocol.
As of 1 January 2018, the DOT updated its 5-panel specifications. The former “Opiates” category was renamed “Opioids” and expanded to include four semi-synthetic opioids, hydrocodone, hydromorphone, oxycodone and oxymorphone. The Amphetamines category was also updated. The result: while the panel count remains at 5, confirmation testing now covers 14 individual substances.
Despite the expanded substance list, collectors still check the single “5-panel” box (THC, COC, PCP, OPI, AMP) in Step 1 of the Custody and Control Form. The expanded opioid confirmatory testing happens at the laboratory level, it does not change the collection procedure or the form used.
What to bring
- Valid, unexpired government-issued photo ID
- Employer test order or authorization if provided
- Employer name and contact for result delivery
- List of any current prescription medications, disclose during intake
What you receive
- Urine specimen collection under 49 CFR Part 40 chain-of-custody procedures
- SAMHSA-certified laboratory analysis
- MRO-reviewed final result
- Negative results typically within 24–48 hours
The five panels
What the DOT 5 panel drug test screens for
Since January 2018, the panel covers 14 individual substances at the confirmation stage.
| Panel | Substances confirmed | Notes |
|---|---|---|
| Marijuana (THC) | THC (delta-9-tetrahydrocannabinol metabolite) | A positive result cannot be excused by a state medical marijuana card, prescription or state law. Marijuana remains a Schedule I controlled substance under federal law. |
| Cocaine (COC) | Cocaine (benzoylecgonine metabolite) | A Schedule II controlled substance. A positive result requires immediate removal from safety-sensitive duties pending MRO review. |
| Amphetamines (AMP) updated 2018 | Amphetamine, methamphetamine, MDMA, MDA | The 2018 update added initial testing for MDA and removed testing for MDEA from this category. |
| Opioids (OPI) expanded 2018 | Codeine, morphine, 6-AM (heroin metabolite), hydrocodone, hydromorphone, oxycodone, oxymorphone | Formerly “Opiates”, renamed and significantly expanded in January 2018. Common prescription painkillers now fall within this panel. |
| Phencyclidine (PCP) | Phencyclidine | A Schedule II hallucinogenic drug with no accepted medical use in safety-sensitive transportation roles. |
The most significant change to DOT drug testing in many years, expanding the opioids panel to address the opioid crisis: “Opiates” was renamed to “Opioids”; hydrocodone, hydromorphone, oxycodone and oxymorphone were added; initial testing for MDA was added under Amphetamines while MDEA testing was removed. The result is 14 total substances under 5 panels, up from 8.
Who must be tested
Safety-sensitive roles that require the DOT 5 panel test
Required for any employee in a safety-sensitive position regulated by a DOT operating agency.
CDL truck drivers (FMCSA)
All commercial motor vehicle drivers holding a CDL who operate vehicles over 26,001 lbs, carry 16 or more passengers, or transport placarded hazardous materials.
Aviation personnel (FAA)
Flight crew, air traffic controllers, flight instructors, aircraft maintenance technicians and other safety-sensitive aviation roles.
Railroad employees (FRA)
Train operators, locomotive engineers, conductors, track maintenance workers and other covered railroad roles.
Transit workers (FTA)
Public transit vehicle operators, mechanics, armed security and transit system control centre employees in safety-sensitive positions.
Pipeline workers (PHMSA)
Employees performing operations, maintenance and emergency response functions on regulated natural gas and hazardous liquid pipeline systems.
Motor carrier employers
Trucking companies, logistics operators and fleet owners responsible for ensuring all CDL drivers complete required DOT drug testing at every required stage.
DOT vs non-DOT
DOT 5 panel vs non-DOT 5 panel, key differences
Both are “5-panel tests” but they are not interchangeable. If your employer requires DOT testing, a non-DOT test result cannot be substituted.
| Feature | DOT 5 panel | Non-DOT 5 panel |
|---|---|---|
| Governing regulation | 49 CFR Part 40, federal mandate | Employer-defined policy |
| Laboratory requirement | SAMHSA-certified only | Any certified lab |
| Chain of custody | Strict federal CCF form required | Standard chain of custody, less rigid |
| MRO review | Required on all non-negative results | Optional, employer discretion |
| Opioid sub-panel | 7 opioids including semi-synthetics | Typically codeine & morphine only |
| Amphetamine sub-panel | Amphetamine, methamphetamine, MDMA, MDA | Amphetamine & methamphetamine typically |
| Interchangeable for compliance | Accepted for all DOT requirements | Cannot substitute for a DOT test |
| Result reporting | MRO reports to employer and Clearinghouse | Lab or employer-defined |
If your role is safety-sensitive under any DOT operating agency (FMCSA, FAA, FRA, FTA, PHMSA), you need DOT testing, and a non-DOT test will not satisfy that requirement. Call us at (816) 442-0295 and we will confirm which applies in under two minutes.
Why Midwest Identity Services
Why Kansas City carriers choose us for DOT 5 panel testing
Every DOT 5 panel test we conduct follows current 49 CFR Part 40 specifications, including the expanded 2018 opioid panel.
Current 2018 specifications
Our DOT 5 panel tests use the updated specifications effective 1 January 2018, including the expanded opioids panel covering hydrocodone, oxycodone, hydromorphone and oxymorphone. You will not receive an outdated test that misses current federal requirements.
SAMHSA-certified lab analysis
DOT specimens are analysed only by SAMHSA-certified laboratories, exactly as federal regulations require.
Federal chain of custody
Collection follows the federal Custody and Control Form procedure precisely, because a non-compliant collection can invalidate a result entirely.
MRO review on every non-negative
The MRO contacts the donor to verify any legitimate medical explanation before a final result reaches the employer.
All six DOT test types
Pre-employment, random, reasonable suspicion, post-accident, return-to-duty and follow-up testing. See the full DOT programme.
Employer program support
DOT 5 panel testing is often part of a broader compliance programme, random pools, Clearinghouse queries and PSP reports. Set one up with us.
Book your DOT 5 panel drug test today
Collected under 49 CFR Part 40, analysed by a SAMHSA-certified laboratory and reviewed by a Medical Review Officer.
8101 E. Bannister Rd, Kansas City, MO 64134 · $60–$99 based on services needed